Literature DB >> 6549747

Serum-treated antigen-antibody complexes inhibit the production of C2 and factor B by mononuclear phagocytes.

K Whaley, D Lappin, A O Hamilton.   

Abstract

Antigen-antibody complexes enhanced the synthesis of C2 and factor B by human monocytes and macrophages, and C2 by guinea-pig macrophages. In contrast complexes that had been treated with serum inhibited the production of these components. The inhibitory effect of serum-treated complexes was abrogated by Fab fragments of anti-C3, anti-C3c and anti-C3d. It is therefore probable that inhibition was mediated by a C3 fragment bound to the complex. The enhancing effect of untreated complexes was reversible by serum-treated complexes, and the inhibitory action of serum-treated complexes was counteracted by untreated complexes. Such a system may be important in the regulation of the synthesis of complement components in response to local requirements.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6549747      PMCID: PMC1453902     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  In vitro studies of immunologically induced secretion of mediators from cells and related phenomena.

Authors:  E L Becker; P M Henson
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

2.  The purification and properties of the second component of human complement.

Authors:  M A Kerr; R R Porter
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

3.  Enhancement of monocyte complement component synthesis by antigen--antibody complexes.

Authors:  A McPhaden; D Lappin; K Whaley
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

4.  Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages.

Authors:  R J Bonney; P Naruns; P Davies; J L Humes
Journal:  Prostaglandins       Date:  1979-10

5.  Effect of histamine on monocyte complement production. II. Modulation of protein secretion, degradation and synthesis.

Authors:  D Lappin; H L Moseley; K Whaley
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

6.  Inhibition of immune precipitation by complement.

Authors:  J A Schifferli; S R Bartolotti; D K Peters
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

7.  Effects of histamine on monocyte complement production. I. Inhibition of C2 production mediated by its action on H2 receptors.

Authors:  D Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

8.  Studies on the mechanism of solubilization of immune precipitates by serum.

Authors:  J Czop; V Nussenzweig
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

9.  Synthesis of the second component of complement by long-term primary cultures of human monocytes.

Authors:  L P Einstein; E E Schneeberger; H R Colten
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

10.  Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.

Authors:  K Whaley
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Complement biosynthesis by mononuclear phagocytes.

Authors:  A R McPhaden; K Whaley
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 2.  Synthesis of complement by macrophages and modulation of their functions through complement activation.

Authors:  H P Hartung; U Hadding
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytes.

Authors:  D Lappin; D W Riches; B Damerau; K Whaley
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

4.  Role of C3 in the control of monocyte C2 production.

Authors:  A O Hamilton; L Morrison; W S Kilpatrick; D Lappin; J C Bensa; D W Riches; K Whaley
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

5.  Control of monocyte C2 production by cyclic AMP.

Authors:  D Lappin; K Whaley
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.